1. Fryar CD, Ostchega Y, Hales CM, et al. Hypertension prevalence and control among adults: United States, 2015–2016. NCHS Data Brief. 2017(289):1-8.
2. Ambrosius WT, Sink KM, Foy CG, et al. The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: The Systolic Blood Pressure Intervention Trial (SPRINT). Clin Trials. 2014;11:532-546.
3. Lawes CM, Bennett DA, Feigin VL, Rodgers A. Blood pressure and stroke: an overview of published reviews. Stroke. 2017;35:776-785.
4. Zanchetti A, Thomopoulos C, Parati G. Randomized controlled trials of blood pressure lowering in hypertension: A critical reappraisal. Circ Res . 2015;116:1058-1073.
5. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/ AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71:e127-e248.
6. Grol R. Successes and failures in the implementation of evidence-based guidelines for clinical practice. Med Care. 2001;39:II46-II54.
7. Brush JE, Handberg EM, Biga C, et al. 2015 ACC health policy statement on cardiovascular team-based care and the role of advanced practice providers. J Am Coll Cardiol. 2015;65:2118-2136.
8. Centers for Disease Control and Prevention. Best practices for cardiovascular disease prevention programs: a guide to effective health care system interventions and community programs linked to clinical services, promoting team-based care to improve high blood pressure control. www.cdc.gov/dhdsp/pubs/guides/best-practices/team-based-care.htm . Accessed April 30, 2020.
9. Centers for Disease Control and Prevention. Task Force recommends team-based care for improving blood pressure [press release]. May 15, 2012. www.cdc.gov/media/releases/2012/p0515_bp_control.html
10. Mitchell P, Wynia M, Golden R, et al. Core principles & values of effective team-based health care. 2012. Institute of Medicine, Washington, DC.
11. Campbell SM, Hann M, Hacker J, et al. Identifying predictors of high-quality care in English general practice: observational study. BMJ. 2001;323:784-787.
12. Shojania KG, Ranji SR, McDonald KM, et al. Effects of quality improvement strategies for type 2 diabetes on glycemic control: a meta-regression analysis. JAMA. 2006;296:427-440.
13. Walsh JM, McDonald KM, Shojania KG, et al. Quality improvement strategies for hypertension management: a systematic review. Med Care. 2006;44:646-657.
14. Wagner E. The role of patient care teams in chronic disease management. BMJ. 2000;320:560-572.
15. Coleman K, Reid R. Continuous and team-based healing relationships: improving patient care through teams. In: Phillips KE, Weir V, eds. Safety Net Medical Home Initiative Implementation Guide Series. 2nd ed. Seattle, WA: Qualis Health and The MacColl Center for Health Care Innovation at the Group Health Research Institute; 2013.
16. Sinsky CA, Willard-Grace R, Schutzbank AM, et al. In search of joy in practice: a report of 23 high-functioning primary care practices. Ann Fam Med. 2013;11:272-278
17. Howard J, Etz RS, Crocker JB, et al. Maximizing the patient-centered medical home (PCMH) by choosing words wisely. J Am Board Fam Med. 2016;29:248-253.
18. Solberg LI, Crain AL, Tillema JO, et al. Challenges of medical home transformation reported by 118 patient-centered medical home (PCMH) leaders. J Am Board Fam Med. 2014;27:449-457.
19. Crabtree BF, Chase SM, Wise CG, et al. Evaluation of patient centered medical home practice transformation initiatives. Med Care. 2011;49:10-16.
20. Carter BL. Blood pressure control—implementing a team approach. US Cardiol . 2011;8:108-113.
21. Carter BL, Rogers M, Daly J, et al. The potency of team-based care interventions for hypertension: a meta-analysis. Arch Intern Med. 2009;169:1748-1755.
22. Proia KK, Thota AB, Njie GJ, et al. Team-based care and improved blood pressure control: a community guide systematic review. Am J Prev Med. 2014;47:86-99.
23. Santschi V, Chiolero A, Colosimo AL, et al. Improving blood pressure control through pharmacist interventions: a meta-analysis of randomized controlled trials. J Am Heart Assoc. 2014;3:e000718.
24. Shaw RJ, McDuffie JR, Hendrix CC, et al. Effects of nurse-managed protocols in the outpatient management of adults with chronic conditions: a systematic review and meta-analysis. Ann Intern Med. 2014;161:113-121.
25. Carter BL, Coffey CS, Ardery G, et al. Cluster-randomized trial of a physician/pharmacist collaborative model to improve blood pressure control. Circ Cardiovasc Qual Outcomes. 2015;8:235-243
26. Carter BL, Bosworth HB, Green BB. The hypertension team: the role of the pharmacist, nurse and teamwork in hypertension therapy. J Clin Hypertens. 2012;14:51-65.
27. Kennelty KA, Polgreen LA, Carter BL. Team-based care with pharmacists to improve blood pressure: a review of recent literature. Curr Hypertens Rep. 2018;20:1.
28. Brownstein JN, Chowdhury FM, Norris SL, et al. Effectiveness of community health workers in the care of people with hypertension. Am J Prev Med. 2007;32:435-447.
29. Derington CG, King JB, Bryant KB, et al. Cost-effectiveness and challenges of implementing intensive blood pressure goals and team-based care. Curr Hypertens Rep. 2019;21:91.
30. Mills KT, Obst KM, Shen W, et al. Comparative effectiveness of implementation strategies for blood pressure control in hypertensive patients: a systematic review and meta-analysis. Ann Intern Med. 2018;168:110-120.
31. Clark CE, Smith LFP, Taylor RS, et al. Nurse led interventions to improve control of blood pressure in people with hypertension: systematic review and meta-analysis. BMJ. 2010;341:c3995.
32. Santschi V, Chiolero A, Burnand B, et al. Impact of pharmacist care in the management of cardiovascular disease risk factors: a systematic review and meta-analysis of randomized trials. Arch Intern Med. 2011;171:1441-1453.
33. Dennison Himmelfarb CR, Commodore-Mensah Y, Hill MN. Expanding the role of nurses to improve hypertension care and control globally. Ann Glob Health. 2016;82:243-253.
34. Clark CE, Smith LFP, Taylor RS, Campbell JL. Nurse-led interventions used to improve control of high blood pressure in people with diabetes: a systematic review and meta-analysis. DiabetMed. 2011;28:250-261.
35. Zhu X, Wong FKY, Wu CLH. Development and evaluation of a nurse-led hypertension management model: A randomized controlled trial. Int J Nurs Stud. 2018;77:171-178.
36. Spruill TM, Williams O, Teresi JA, et al. Comparative effectiveness of home blood pressure telemonitoring (HBPTM) plus nurse case management versus HBPTM alone among Black and Hispanic stroke survivors: study protocol for a randomized controlled trial. Trials. 2015;16:97.
37. Ogedegbe G. Comparative effectiveness of home BP telemonitoring plus nurse case management (HBPTM+NCM) versus HBPTM alone on systolic BP (SBP) reduction among minority stroke survivors. International Stroke Conference 2020; February 19-21, 2020; Los Angeles, CA. Abstract LB19.
38. Dunn SP, Birtcher KK, Beavers CJ, et al. The role of the clinical pharmacist in the care of patients with cardiovascular disease. J Am Coll Cardiol. 2015;66:2129-2139.
39. Santschi V, Chiolero A, Paradis G et al. Pharmacist interventions to improve cardiovascular disease risk factors in diabetes: a systematic review and meta-analysis of randomized controlled trials. Diabetes Care. 2012;35:2706-2717.
40. Anderegg MD, Gums TH, Uribe L, et al. Pharmacist intervention for blood pressure control in patients with diabetes and/or chronic kidney disease. Pharmacotherapy. 2018;38:309-318.
41. Anderegg MD, Gums TH, Uribe L et al. Physician-pharmacist collaborative management: narrowing the socioeconomic blood pressure gap. Hypertension. 2016;68:1314-1320.
42. Sisson EM, Dixon DL, Kildow DC, et al. Effectiveness of a pharmacist-physician team-based collaboration to improve long-term blood pressure control at an inner-city safety-net clinic. Pharmacotherapy. 2016;36:342-347.
43. Dixon DL, Sisson EM, Parod ED, et al. Pharmacist-physician collaborative care model and time to goal blood pressure in the uninsured population. J Clin Hypertens (Greenwich). 2018;20:88-95.
44. Dixon DL, Parod ED, Sisson EM et al. Impact of a pharmacist-physician collaborative care model on time-in-therapeutic blood pressure range in patients with hypertension. J Am Coll Clin Pharm. 2020;3:404-409.
45. Tsuyuki RT, Houle SK, Charrois TL, et al. Randomized trial of the effect of pharmacist prescribing on improving blood pressure in the community: the Alberta Clinical Trial in Optimizing Hypertension (RxACTION). Circulation. 2015;132:93-100.
46. Tsuyuki RT, Al Hamarneh YN, Jones CA, et al. The effectiveness of pharmacist interventions on cardiovascular risk: The Multicenter Randomized Controlled RxEACH trial. J Am Coll Cardiol. 2016;67:2846-2854.
47. Victor RG, Lynch K, Li N, et al. A cluster-randomized trial of blood-pressure reduction in black barbershops. N Engl J Med. 2018;378:1291-1301.
48. Victor RG, Blyler CA, Li N et al. Sustainability of blood pressure reduction in black barbershops. Circulation. 2019;139:10-19.
49. Panattoni L, Hurlimann L, Wilson C, et al. Workflow standardization of a novel team care model to improve chronic care: a quasi-experimental study. BMC Health Serv Res. 2017;17:286.
50. Chang AR, Bonaparte H, Yule C. Randomized controlled trial comparing a self-guided vs. dietitian-led approach using web-based tools to lower blood pressure: study design and rationale. International Stroke Conference 2020; February 19-21, 2020; Los Angeles, CA. Abstract P169.
51. Stephen C, Halcomb E, Mcinnes S, et al. Improving blood pressure control in primary care: The ImPress study. Int J Nurs Stud. 2019;95:28-33.
52. He J, Shi X, Lin M. Comparative effectiveness of implementation strategies on cardiovascular risk factor control in patients with diabetes: The D4C cluster randomized trial. International Stroke Conference 2020; February 19-21, 2020; Los Angeles, CA. Abstract 17.
53. Jafar TH, Gandhi M, de Silva HA, et al. A community-based intervention for managing hypertension in rural South Asia. N Engl J Med. 2020;382:717-726.
54. Centers for Disease Control and Prevention. Promoting team-based care to improve high blood pressure control. www.cdc.gov/dhdsp/pubs/guides/best-practices/team-based-care.htm . Accessed April 30, 2020.
55. Jacob V, Chattopadhyay SK, Thota AB, et al. Economics of team-based care in controlling blood pressure: a community guide systematic review. Am J Prev Med. 2015;49:772-783.
56. Dehmer SP, Baker-Goering MM, Maciosek MV, et al. Modeled health and economic impact of team-based care for hypertension. Am J Prev Med. 2016;50(5 suppl 1):S34-S44.
57. Zhang D, Wang G, Joo H. A systematic review of economic evidence on community hypertension interventions. Am J Prev Med. 2017;53:S121-S130.
58. Community Preventive Services Task Force. Cardiovascular disease: team-based care to improve blood pressure control. 2011. www.thecommunityguide.org/findings/cardiovascular-disease-team-based-care-improve-blood-pressure-control . Accessed April 30, 2020.
59. Kulchaitanaroaj P, Brooks JM, Ardery G et al. Incremental costs associated with physician and pharmacist collaboration to improve blood pressure control. Pharmacotherapy. 2012;32:772-780.
60. Mason JM, Freemantle N, Gibson JM, New JP. Specialist nurse-led clinics to improve control of hypertension and hyperlipidemia in diabetes. Diabetes Care. 2005;28:40-46.
61. Kulchaitanaroaj P, Brooks JM, Chaiyakunapruk N et al. Cost-utility analysis of physician-pharmacist collaborative intervention for treating hypertension compared with usual care. J Hypertens. 2017;35:178-187.
62. Lall D, Engel N, Devadasan N, et al. Models of care for chronic conditions in low/middle-income countries: a ‘best fit’ framework synthesis. BMJ Glob Health. 2018;3:e001077.
63. Bodenheimer T, Chen E, Bennett HD. Confronting the growing burden of chronic disease: can the U.S. health care workforce do the job? Health Aff (Millwood). 2009;28:64-74.
64. Smith M, Bates DW, Bodenheimer T, Cleary PD. Why pharmacists belong in the medical home. Health Aff (Millwood). 2010;29:906-913.
65. Wright JT, Williamson JD, Whelton PK, et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373:2103-2116.
66. Phillips LS, Branch WT, Cook CB, et al. Clinical inertia. Ann Intern Med. 2001;135:825-834.
67. McManus RJ, Mant J, Franssen M, et al. Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trial. Lancet. 2018;391:949-959.
68. Tucker KL, Sheppard JP, Stevens R, et al. Self-monitoring of blood pressure in hypertension: a systematic review and individual patient data meta-analysis. PLoS Med. 2017;14:e1002389.
69. Casey DE, Thomas RJ, Bhalla V, et al. 2019 AHA/ACC clinical performance and quality measures for adults with high blood pressure: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. J Am Coll Cardiol. 2019;74:2661-2706.